Hippocampus and entorhinal cortex in mild cognitive impairment and early AD

[1]  D. Mann,et al.  The topographic distribution of brain atrophy in Alzheimer's disease , 2004, Acta Neuropathologica.

[2]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[3]  Tuomo Hänninen,et al.  Prevalence of mild cognitive impairment: a population‐based study in elderly subjects , 2002, Acta neurologica Scandinavica.

[4]  M. Albert,et al.  MRI measures of entorhinal cortex vs hippocampus in preclinical AD , 2002, Neurology.

[5]  P. Scheltens,et al.  Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment , 2002, Journal of neurology, neurosurgery, and psychiatry.

[6]  N. Schuff,et al.  Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[7]  D. Bennett,et al.  MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease☆ ☆ This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health. , 2001, Neurobiology of Aging.

[8]  B. Dickerson,et al.  MRI of human entorhinal cortex: a reliable protocol for volumetric measurement , 2001, Neurobiology of Aging.

[9]  A. Convit,et al.  Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.

[10]  H. Soininen,et al.  Midlife vascular risk factors and late-life mild cognitive impairment , 2001, Neurology.

[11]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[12]  A. Rabinstein,et al.  Transplantation of cultured human neuronal cells for patients with stroke , 2000, Neurology.

[13]  D. Bennett,et al.  Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment , 2001, Annals of neurology.

[14]  C. Jack,et al.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.

[15]  C. Jack,et al.  Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.

[16]  R. Killiany,et al.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.

[17]  M. Bobinski,et al.  The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease , 1999, Neuroscience.

[18]  S H Ferris,et al.  Neuropsychological Prediction of Decline to Dementia in Nondemented Elderly , 1999, Journal of geriatric psychiatry and neurology.

[19]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[20]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[21]  G. Frisoni,et al.  Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease , 1999, Neurology.

[22]  H. Soininen,et al.  Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. , 1999, AJNR. American journal of neuroradiology.

[23]  Cees Jonker,et al.  Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment , 1999, Journal of Neurology.

[24]  H. Soininen,et al.  MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. , 1998, AJNR. American journal of neuroradiology.

[25]  H. Soininen,et al.  MRI of the Hippocampus in Alzheimer’s Disease: Sensitivity, Specificity, and Analysis of the Incorrectly Classified Subjects , 1998, Neurobiology of Aging.

[26]  H. Soininen,et al.  Volumes of the Entorhinal and Perirhinal Cortices in Alzheimer’s Disease , 1998, Neurobiology of Aging.

[27]  H. Wiśniewski,et al.  Contribution of Structural Neuroimaging to the Early Diagnosis of Alzheimer's Disease , 1997, International Psychogeriatrics.

[28]  A. Convit,et al.  Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease , 1997, Neurobiology of Aging.

[29]  H. Soininen,et al.  Decline of Frontal Lobe Functions in Subjects with Age-associated Memory Impairment , 1997, Neurology.

[30]  H. Braak,et al.  Staging of Alzheimer-related cortical destruction. , 1997, International psychogeriatrics.

[31]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[32]  Ronald C. Petersen,et al.  Definition, course, and outcome of mild cognitive impairment , 1996 .

[33]  D. Schaid,et al.  Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.

[34]  H. Soininen,et al.  Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions , 1995, Journal of neural transmission. Parkinson's disease and dementia section.

[35]  S Lehéricy,et al.  Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. , 1994, AJNR. American journal of neuroradiology.

[36]  Dc Washington.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[37]  G A Johnson,et al.  In vitro MR microscopy of the hippocampus in Alzheimer's disease , 1993, Neurology.

[38]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[39]  B T Hyman,et al.  Entorhinal cortex pathology in Alzheimer's disease , 1991, Hippocampus.

[40]  G. V. Van Hoesen,et al.  Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. , 1990, Progress in brain research.

[41]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[42]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[43]  L. Berg.  Clinical Dementia Rating (CDR). , 1988, Psychopharmacology bulletin.

[44]  N Butters,et al.  Episodic and semantic memory: a comparison of amnesic and demented patients. , 1987, Journal of clinical and experimental neuropsychology.

[45]  L. Berg,et al.  Clinical Dementia Rating , 1984, British Journal of Psychiatry.

[46]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[47]  E. Kaplan,et al.  The Boston naming test , 2001 .

[48]  Elbert W. Russell,et al.  A multiple scoring method for the assessment of complex memory functions. , 1975 .

[49]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[50]  Arthur L. Benton,et al.  Word fluency and brain damage , 1967 .

[51]  R. Reitan.  Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .